Patented Medicine Prices Review Board Canada

Subjects

• Government12
• Environment3
• Economy3

Datasets can carry more than one subject, so these may sum past the total.

Licences

• ca-ogl-lgo16

As published by the portal. Licence identifiers are not standardised between countries.

Formats

• HTML26
• PDF6

Counted across files, as declared by the catalogue.

Datasets (16 of 16)

This catalogue publishes no address for its individual dataset records, so these titles are not links. Search for them on https://open.canada.ca/data/api/3/action.

• Patented Medicine Prices Review Board 2024-25 Departmental Plan
  html · updated 2026-04-16
• The Patented Medicine Prices Review Board’s 2024–25 Departmental Results Report
  html · updated 2026-04-16
• Patented Medicine Prices Review Board 2023-24 Departmental Plan
  html · updated 2026-04-16
• The Patented Medicine Prices Review Board’s 2023–24 Departmental Results Report
  html · updated 2026-04-16
• The Patented Medicine Prices Review Board’s 2022–23 Departmental Results Report
  html · updated 2026-04-16
• 2023 to 2027 Departmental Sustainable Development Strategy
  html · updated 2026-04-16
• 2024 to 2025 Departmental Sustainable Development Strategy Report
  html · updated 2026-04-16
• 2023 to 2024 Departmental Sustainable Development Strategy Report
  html · updated 2026-04-16
• Patented Medicine Prices Review Board 2026-27 Departmental Plan
  html · updated 2026-04-16
• 2023 Annual Report
  html · updated 2026-04-16
• 2024 Annual Report
  html · updated 2026-04-16
• 2022 Annual Report
  html · updated 2026-04-16
• Patented Medicine Prices Review Board 2025-26 Departmental Plan
  html · updated 2026-04-16
• Accessibility Plan for the Patented Medicine Prices Review Board: Progress Report, December 2023
  pdf · updated 2024-11-20
• Transition Binder for New Chairperson, Thomas Digby, 2023
  pdf · updated 2024-11-20
• Accessibility Plan for the Patented Medicine Prices Review Board
  pdf · updated 2024-11-20